"If the predict-resect-and-discard paradigm becomes standard of care, then obviously the responsibility then lies on the shoulders of the endoscopist rather than the pathologist," he said, adding that ...
SINGAPORE — When is stage III non–small cell lung cancer (NSCLC) resectable? The introduction of "novel therapeutics into the neoadjuvant space and now the perioperative space has really transformed ...
Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer ...